Alethia BioTherapeutics' Seed VC Round

Alethia BioTherapeutics raised a round of funding on May 11, 2009.

Alethia BioTherapeutics is a biotechnology company that develops monoclonal antibody therapeutics to clinically relevant targets identified using its STAR discovery technology.…

Articles about Alethia BioTherapeutics' Seed VC Round: